Table 1.
Baseline Characteristics of Women Enrolled in the Trial with Available Vitamin D Levels (n=884)
| |
|
Low vitamin D (n = 347) |
Adequate vitamin D (n = 537) |
|---|---|---|---|
| Variable | Mean ± SD or frequency (%) | Mean ± SD or frequency (%) | |
| Age | |||
| Less than 20 years | 45 (12.97) | 71 (13.22) | |
| 20–24 years | 144 (41.50) | 213 (39.66) | |
| 25–29 years | 105 (30.26) | 166 (30.91) | |
| Greater than or equal to 30 years | 53 (15.27) | 87 (16.20) | |
| WHO HIV stage | |||
| I | 278 (80.12) | 457 (85.10) | |
| II | 60 (17.29) | 75 (13.97) | |
| III | 9 (2.59) | 5 (0.93) | |
| CD4 category, cells/μL | 413.45±202.32 | 428.65±210.14 | |
| Body Mass Index (BMI), kg/m2 | 23.01±3.20 | 23.39±3.20 | |
| Height, cm | 156.48±5.86 | 156.86±5.94 | |
| Mid–upper arm circumference (MUAC), cm | 25.37±2.85 | 25.67±2.85 | |
| Hemoglobin at baseline, g/L | 93.50±17.29 | 95.25±16.70 | |
| Vitamin D [Serum 25(OH)D] at baseline, ng/mL | 24.22±6.16 | 43.07±9.40 | |
SD, standard deviation.